Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-05-28

AUTHORS

Marie-Léa Gauci, Philippe Boudou, Barouyr Baroudjian, Tiphaine Vidal-Trecan, Laetitia Da Meda, Isabelle Madelaine-Chambrin, Nicole Basset-Seguin, Martine Bagot, Cécile Pages, Samia Mourah, Matthieu Resche-Rigon, Sylvine Pinel, Marion Sassier, Franck Rouby, Pirayeh Eftekhari, Céleste Lebbé, Jean-François Gautier

ABSTRACT

Anti-PD-1 and anti-CTLA-4 antibodies cause immune-related side effects such as autoimmune type 1 diabetes (T1D). It has also been suggested that by increasing TNF-α, IL-2 and IFN-γ production, anti-PD-1 and/or anti-CTLA-4 treatment could affect pancreatic beta cell function and insulin sensitivity. This study was based on a retrospective observational analysis from 2 July 2014 to 27 June 2016, which evaluated the occurrence of T1D and changes in glycemia and C-reactive protein (CRP) plasma concentrations in patients undergoing anti-PD-1 and/or anti-CTLA-4 treatment for melanoma at the Saint Louis Hospital. All cases of T1D that developed during immunotherapy registered in the French Pharmacovigilance Database (FPVD) were also considered. Among the 132 patients included, 3 cases of T1D occurred. For the remaining subjects, blood glucose was not significantly affected by anti-PD-1 treatment, but CRP levels (mg/l) significantly increased during anti-PD-1 treatment (p = 0.017). However, 1 case of type 2 diabetes (T2D) occurred (associated with a longer therapy duration). Moreover, glycemia of patients pretreated (n = 44) or concomitantly treated (n = 8) with anti-CTLA-4 tended to increase during anti-PD-1 therapy (p = 0.068). From the FPVD, we obtained 14 cases of T1D that occurred during immunotherapy and were primarily characterized by the rapidity and severity of onset. In conclusion, in addition to inducing this rare immune-related diabetes condition, anti-PD-1 treatment appears to increase CRP levels, a potential inflammatory trigger of insulin resistance, but without any short-term impact on blood glucose level. More... »

PAGES

1197-1208

References to SciGraph publications

Journal

TITLE

Cancer Immunology, Immunotherapy

ISSUE

8

VOLUME

67

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00262-018-2178-0

DOI

http://dx.doi.org/10.1007/s00262-018-2178-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1104264568

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29808365


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CTLA-4 Antigen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "France", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Incidence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melanoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Programmed Cell Death 1 Receptor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "AP-HP Dermatology Department, Saint-Louis Hospital, INSERM U976, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, 1, Avenue Claude Vellefaux, 75010, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.413328.f", 
          "name": [
            "AP-HP Dermatology Department, Saint-Louis Hospital, INSERM U976, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, 1, Avenue Claude Vellefaux, 75010, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gauci", 
        "givenName": "Marie-L\u00e9a", 
        "id": "sg:person.011002122115.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011002122115.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP Hormonology Department, Saint-Louis Hospital, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, Paris, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "AP-HP Hormonology Department, Saint-Louis Hospital, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boudou", 
        "givenName": "Philippe", 
        "id": "sg:person.01264446127.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264446127.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP Dermatology Department, Saint-Louis Hospital, INSERM U976, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, 1, Avenue Claude Vellefaux, 75010, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.413328.f", 
          "name": [
            "AP-HP Dermatology Department, Saint-Louis Hospital, INSERM U976, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, 1, Avenue Claude Vellefaux, 75010, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Baroudjian", 
        "givenName": "Barouyr", 
        "id": "sg:person.0645204640.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645204640.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP Diabetology Department, Lariboisi\u00e8re Hospital, INSERM U1138; Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, Paris, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "AP-HP Diabetology Department, Lariboisi\u00e8re Hospital, INSERM U1138; Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vidal-Trecan", 
        "givenName": "Tiphaine", 
        "id": "sg:person.01112142070.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112142070.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP Dermatology Department, Saint-Louis Hospital, INSERM U976, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, 1, Avenue Claude Vellefaux, 75010, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.413328.f", 
          "name": [
            "AP-HP Dermatology Department, Saint-Louis Hospital, INSERM U976, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, 1, Avenue Claude Vellefaux, 75010, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Da Meda", 
        "givenName": "Laetitia", 
        "id": "sg:person.015421213413.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015421213413.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP Pharmacology Department, Saint-Louis Hospital, INSERM U976, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.413328.f", 
          "name": [
            "AP-HP Pharmacology Department, Saint-Louis Hospital, INSERM U976, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Madelaine-Chambrin", 
        "givenName": "Isabelle", 
        "id": "sg:person.0757312465.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757312465.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP Dermatology Department, Saint-Louis Hospital, INSERM U976, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, 1, Avenue Claude Vellefaux, 75010, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.413328.f", 
          "name": [
            "AP-HP Dermatology Department, Saint-Louis Hospital, INSERM U976, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, 1, Avenue Claude Vellefaux, 75010, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Basset-Seguin", 
        "givenName": "Nicole", 
        "id": "sg:person.01266110107.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266110107.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP Dermatology Department, Saint-Louis Hospital, INSERM U976, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, 1, Avenue Claude Vellefaux, 75010, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.413328.f", 
          "name": [
            "AP-HP Dermatology Department, Saint-Louis Hospital, INSERM U976, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, 1, Avenue Claude Vellefaux, 75010, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bagot", 
        "givenName": "Martine", 
        "id": "sg:person.0606303163.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606303163.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP Dermatology Department, Saint-Louis Hospital, INSERM U976, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, 1, Avenue Claude Vellefaux, 75010, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.413328.f", 
          "name": [
            "AP-HP Dermatology Department, Saint-Louis Hospital, INSERM U976, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, 1, Avenue Claude Vellefaux, 75010, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pages", 
        "givenName": "C\u00e9cile", 
        "id": "sg:person.01125647410.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125647410.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP Pharmacogenomic Laboratory, Saint-Louis Hospital, INSERM U976, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.413328.f", 
          "name": [
            "AP-HP Pharmacogenomic Laboratory, Saint-Louis Hospital, INSERM U976, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mourah", 
        "givenName": "Samia", 
        "id": "sg:person.01141165754.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141165754.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP Statistics Department, Saint-Louis Hospital, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, Paris, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "AP-HP Statistics Department, Saint-Louis Hospital, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Resche-Rigon", 
        "givenName": "Matthieu", 
        "id": "sg:person.01036155166.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036155166.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP Regional Pharmacologilance Center, Fernand Widal Hospital, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.508487.6", 
          "name": [
            "AP-HP Regional Pharmacologilance Center, Fernand Widal Hospital, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pinel", 
        "givenName": "Sylvine", 
        "id": "sg:person.07443060126.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07443060126.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Regional Pharmacovigilance Center of Caen, Caen University Hospital, Caen, France", 
          "id": "http://www.grid.ac/institutes/grid.411149.8", 
          "name": [
            "Regional Pharmacovigilance Center of Caen, Caen University Hospital, Caen, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sassier", 
        "givenName": "Marion", 
        "id": "sg:person.0661613401.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661613401.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology, Regional Pharmacovigilance Center of Marseille, Aix-Marseille University, Marseille, France", 
          "id": "http://www.grid.ac/institutes/grid.5399.6", 
          "name": [
            "Department of Clinical Pharmacology, Regional Pharmacovigilance Center of Marseille, Aix-Marseille University, Marseille, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rouby", 
        "givenName": "Franck", 
        "id": "sg:person.0755365673.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755365673.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP Regional Pharmacologilance Center, Fernand Widal Hospital, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.508487.6", 
          "name": [
            "AP-HP Regional Pharmacologilance Center, Fernand Widal Hospital, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eftekhari", 
        "givenName": "Pirayeh", 
        "id": "sg:person.0602343615.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602343615.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP Dermatology Department, Saint-Louis Hospital, INSERM U976, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, 1, Avenue Claude Vellefaux, 75010, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.413328.f", 
          "name": [
            "AP-HP Dermatology Department, Saint-Louis Hospital, INSERM U976, Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, 1, Avenue Claude Vellefaux, 75010, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lebb\u00e9", 
        "givenName": "C\u00e9leste", 
        "id": "sg:person.01054652653.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054652653.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AP-HP Diabetology Department, Lariboisi\u00e8re Hospital, INSERM U1138; Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, Paris, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "AP-HP Diabetology Department, Lariboisi\u00e8re Hospital, INSERM U1138; Universit\u00e9 Paris Diderot-Paris VII, Sorbonne Paris Cit\u00e9, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gautier", 
        "givenName": "Jean-Fran\u00e7ois", 
        "id": "sg:person.014551573472.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014551573472.10"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/ni.1835", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021874855", 
          "https://doi.org/10.1038/ni.1835"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri2925", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041192648", 
          "https://doi.org/10.1038/nri2925"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm.1964", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018401818", 
          "https://doi.org/10.1038/nm.1964"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.ijo.0803744", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033023159", 
          "https://doi.org/10.1038/sj.ijo.0803744"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00262-015-1689-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016520120", 
          "https://doi.org/10.1007/s00262-015-1689-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00262-016-1835-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007445664", 
          "https://doi.org/10.1007/s00262-016-1835-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12185-016-2101-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007028663", 
          "https://doi.org/10.1007/s12185-016-2101-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00262-017-2033-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1086099345", 
          "https://doi.org/10.1007/s00262-017-2033-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00393-014-1415-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046203416", 
          "https://doi.org/10.1007/s00393-014-1415-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00592-014-0647-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034654942", 
          "https://doi.org/10.1007/s00592-014-0647-2"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-05-28", 
    "datePublishedReg": "2018-05-28", 
    "description": "Anti-PD-1 and anti-CTLA-4 antibodies cause immune-related side effects such as autoimmune type 1 diabetes (T1D). It has also been suggested that by increasing TNF-\u03b1, IL-2 and IFN-\u03b3 production, anti-PD-1 and/or anti-CTLA-4 treatment could affect pancreatic beta cell function and insulin sensitivity. This study was based on a retrospective observational analysis from 2 July 2014 to 27 June 2016, which evaluated the occurrence of T1D and changes in glycemia and C-reactive protein (CRP) plasma concentrations in patients undergoing anti-PD-1 and/or anti-CTLA-4 treatment for melanoma at the Saint Louis Hospital. All cases of T1D that developed during immunotherapy registered in the French Pharmacovigilance Database (FPVD) were also considered. Among the 132 patients included, 3 cases of T1D occurred. For the remaining subjects, blood glucose was not significantly affected by anti-PD-1 treatment, but CRP levels (mg/l) significantly increased during anti-PD-1 treatment (p\u2009=\u20090.017). However, 1 case of type 2 diabetes (T2D) occurred (associated with a longer therapy duration). Moreover, glycemia of patients pretreated (n\u2009=\u200944) or concomitantly treated (n\u2009=\u20098) with anti-CTLA-4 tended to increase during anti-PD-1 therapy (p\u2009=\u20090.068). From the FPVD, we obtained 14 cases of T1D that occurred during immunotherapy and were primarily characterized by the rapidity and severity of onset. In conclusion, in addition to inducing this rare immune-related diabetes condition, anti-PD-1 treatment appears to increase CRP levels, a potential inflammatory trigger of insulin resistance, but without any short-term impact on blood glucose level.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00262-018-2178-0", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1096240", 
        "issn": [
          "0340-7004", 
          "1432-0851"
        ], 
        "name": "Cancer Immunology, Immunotherapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "67"
      }
    ], 
    "keywords": [
      "anti-PD-1 treatment", 
      "cases of T1D", 
      "French Pharmacovigilance Database", 
      "C-reactive protein", 
      "type 2 diabetes", 
      "CRP levels", 
      "anti-PD-1 therapy", 
      "autoimmune type 1 diabetes", 
      "pancreatic beta-cell function", 
      "occurrence of T1D", 
      "retrospective observational analysis", 
      "IFN-\u03b3 production", 
      "Saint-Louis Hospital", 
      "beta-cell function", 
      "type 1 diabetes", 
      "severity of onset", 
      "blood glucose levels", 
      "inflammatory triggers", 
      "retrospective study", 
      "insulin resistance", 
      "metastatic melanoma", 
      "IL-2", 
      "insulin sensitivity", 
      "blood glucose", 
      "pharmacovigilance database", 
      "glucose levels", 
      "diabetes condition", 
      "side effects", 
      "T1D", 
      "patients", 
      "immunotherapy", 
      "type 1", 
      "diabetes", 
      "cell function", 
      "glycemia", 
      "treatment", 
      "melanoma", 
      "observational analysis", 
      "short-term impact", 
      "TNF", 
      "hospital", 
      "therapy", 
      "cases", 
      "levels", 
      "severity", 
      "antibodies", 
      "onset", 
      "study", 
      "glucose", 
      "occurrence", 
      "subjects", 
      "conclusion", 
      "triggers", 
      "database", 
      "protein", 
      "sensitivity", 
      "effect", 
      "resistance", 
      "changes", 
      "concentration", 
      "function", 
      "addition", 
      "impact", 
      "rapidity", 
      "analysis", 
      "production", 
      "conditions"
    ], 
    "name": "Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a retrospective study", 
    "pagination": "1197-1208", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1104264568"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00262-018-2178-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29808365"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00262-018-2178-0", 
      "https://app.dimensions.ai/details/publication/pub.1104264568"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:44", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_784.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00262-018-2178-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00262-018-2178-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00262-018-2178-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00262-018-2178-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00262-018-2178-0'


 

This table displays all metadata directly associated to this object as RDF triples.

380 TRIPLES      21 PREDICATES      122 URIs      103 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00262-018-2178-0 schema:about N099319a61c7a4680a2e8932d627fe438
2 N13d1ab75ce68490e9c2b5b838d26fdf6
3 N2108c2b4750e40f3a4ab61b82cda44c0
4 N289bafe4653a40d5a59bfb6d2c84a135
5 N35702b533c8e4b70ab63047ac362b57f
6 N473cc395457f47908af03df1b400541d
7 Na611e7b16be247e5b36a313e4f56c928
8 Nb4689036456d47e38736d8f76ae0a8ad
9 Nb7a59aaa004d42efaad0de4afea580b6
10 Nc5b0c6138d314ddfbdf1940294700c67
11 Nca7ac64e52eb433e813e050dfcc1eddb
12 Ncf42516f8c224711ba84f33f89555f27
13 Nd235dc8eb442488087db3bbb6a5d232d
14 Ndf6b459c94114249a48d504d237a1cef
15 Ne1bb190f4be74d6cb7188f219c22b8dc
16 Neb81680cc3b64cb1a240a72f5c76eaca
17 Nf597e8851f8b41e1bfa8cd15b99139ff
18 Nf5b743bc1bba41148486e9fe54ba4f80
19 Nf8338beeeeef41989a31d96aef3fa454
20 anzsrc-for:11
21 anzsrc-for:1103
22 anzsrc-for:1107
23 schema:author N959e2770ebed47e4923800f9a36b1baa
24 schema:citation sg:pub.10.1007/s00262-015-1689-1
25 sg:pub.10.1007/s00262-016-1835-4
26 sg:pub.10.1007/s00262-017-2033-8
27 sg:pub.10.1007/s00393-014-1415-y
28 sg:pub.10.1007/s00592-014-0647-2
29 sg:pub.10.1007/s12185-016-2101-4
30 sg:pub.10.1038/ni.1835
31 sg:pub.10.1038/nm.1964
32 sg:pub.10.1038/nri2925
33 sg:pub.10.1038/sj.ijo.0803744
34 schema:datePublished 2018-05-28
35 schema:datePublishedReg 2018-05-28
36 schema:description Anti-PD-1 and anti-CTLA-4 antibodies cause immune-related side effects such as autoimmune type 1 diabetes (T1D). It has also been suggested that by increasing TNF-α, IL-2 and IFN-γ production, anti-PD-1 and/or anti-CTLA-4 treatment could affect pancreatic beta cell function and insulin sensitivity. This study was based on a retrospective observational analysis from 2 July 2014 to 27 June 2016, which evaluated the occurrence of T1D and changes in glycemia and C-reactive protein (CRP) plasma concentrations in patients undergoing anti-PD-1 and/or anti-CTLA-4 treatment for melanoma at the Saint Louis Hospital. All cases of T1D that developed during immunotherapy registered in the French Pharmacovigilance Database (FPVD) were also considered. Among the 132 patients included, 3 cases of T1D occurred. For the remaining subjects, blood glucose was not significantly affected by anti-PD-1 treatment, but CRP levels (mg/l) significantly increased during anti-PD-1 treatment (p = 0.017). However, 1 case of type 2 diabetes (T2D) occurred (associated with a longer therapy duration). Moreover, glycemia of patients pretreated (n = 44) or concomitantly treated (n = 8) with anti-CTLA-4 tended to increase during anti-PD-1 therapy (p = 0.068). From the FPVD, we obtained 14 cases of T1D that occurred during immunotherapy and were primarily characterized by the rapidity and severity of onset. In conclusion, in addition to inducing this rare immune-related diabetes condition, anti-PD-1 treatment appears to increase CRP levels, a potential inflammatory trigger of insulin resistance, but without any short-term impact on blood glucose level.
37 schema:genre article
38 schema:isAccessibleForFree false
39 schema:isPartOf N05a9348f05cf41cebe513453817cef07
40 N7305fea379c6420287ce0854ffd2407b
41 sg:journal.1096240
42 schema:keywords C-reactive protein
43 CRP levels
44 French Pharmacovigilance Database
45 IFN-γ production
46 IL-2
47 Saint-Louis Hospital
48 T1D
49 TNF
50 addition
51 analysis
52 anti-PD-1 therapy
53 anti-PD-1 treatment
54 antibodies
55 autoimmune type 1 diabetes
56 beta-cell function
57 blood glucose
58 blood glucose levels
59 cases
60 cases of T1D
61 cell function
62 changes
63 concentration
64 conclusion
65 conditions
66 database
67 diabetes
68 diabetes condition
69 effect
70 function
71 glucose
72 glucose levels
73 glycemia
74 hospital
75 immunotherapy
76 impact
77 inflammatory triggers
78 insulin resistance
79 insulin sensitivity
80 levels
81 melanoma
82 metastatic melanoma
83 observational analysis
84 occurrence
85 occurrence of T1D
86 onset
87 pancreatic beta-cell function
88 patients
89 pharmacovigilance database
90 production
91 protein
92 rapidity
93 resistance
94 retrospective observational analysis
95 retrospective study
96 sensitivity
97 severity
98 severity of onset
99 short-term impact
100 side effects
101 study
102 subjects
103 therapy
104 treatment
105 triggers
106 type 1
107 type 1 diabetes
108 type 2 diabetes
109 schema:name Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a retrospective study
110 schema:pagination 1197-1208
111 schema:productId N8a1a91d9fc0b41b5921c3c5d7d2f8cd7
112 Nc0cf6d16b5744b20b6e5588cf72f68ec
113 Nef53b4f6de4841d88763e88a06b83585
114 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104264568
115 https://doi.org/10.1007/s00262-018-2178-0
116 schema:sdDatePublished 2022-10-01T06:44
117 schema:sdLicense https://scigraph.springernature.com/explorer/license/
118 schema:sdPublisher N088f7ec29cca4df1a57aa89eddadae57
119 schema:url https://doi.org/10.1007/s00262-018-2178-0
120 sgo:license sg:explorer/license/
121 sgo:sdDataset articles
122 rdf:type schema:ScholarlyArticle
123 N05a9348f05cf41cebe513453817cef07 schema:volumeNumber 67
124 rdf:type schema:PublicationVolume
125 N088f7ec29cca4df1a57aa89eddadae57 schema:name Springer Nature - SN SciGraph project
126 rdf:type schema:Organization
127 N099319a61c7a4680a2e8932d627fe438 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Aged
129 rdf:type schema:DefinedTerm
130 N13d1ab75ce68490e9c2b5b838d26fdf6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name France
132 rdf:type schema:DefinedTerm
133 N2108c2b4750e40f3a4ab61b82cda44c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Aged, 80 and over
135 rdf:type schema:DefinedTerm
136 N25687e812b814b52bf72a7ee35838654 rdf:first sg:person.0755365673.35
137 rdf:rest N731857ee7d2b413484bf17d3525998aa
138 N289bafe4653a40d5a59bfb6d2c84a135 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Melanoma
140 rdf:type schema:DefinedTerm
141 N2a0532f017404560b19008491d9494a7 rdf:first sg:person.0757312465.10
142 rdf:rest N3b3e2a954b0844969b5a2c85d61976c7
143 N35702b533c8e4b70ab63047ac362b57f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Immunotherapy
145 rdf:type schema:DefinedTerm
146 N368035b43be346e896289202a58332fe rdf:first sg:person.01036155166.50
147 rdf:rest Nff249fe6b2604d9baa777605380a2c00
148 N3b3e2a954b0844969b5a2c85d61976c7 rdf:first sg:person.01266110107.91
149 rdf:rest Nd0c6c659bb2e41bca0cd718121d7deab
150 N3f13f1dbc8344966a5d567e91aca9c23 rdf:first sg:person.01054652653.34
151 rdf:rest N5e20f437f4924e749f9bd99242edfa09
152 N3f7263a9ee234d29b370922233208814 rdf:first sg:person.01264446127.83
153 rdf:rest N92ebd64897fb4d3591984d3ec0fa3ee5
154 N430c1d0cb2dc4e7fbcb806880ab2e37f rdf:first sg:person.015421213413.19
155 rdf:rest N2a0532f017404560b19008491d9494a7
156 N473cc395457f47908af03df1b400541d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Female
158 rdf:type schema:DefinedTerm
159 N5e20f437f4924e749f9bd99242edfa09 rdf:first sg:person.014551573472.10
160 rdf:rest rdf:nil
161 N7305fea379c6420287ce0854ffd2407b schema:issueNumber 8
162 rdf:type schema:PublicationIssue
163 N731857ee7d2b413484bf17d3525998aa rdf:first sg:person.0602343615.33
164 rdf:rest N3f13f1dbc8344966a5d567e91aca9c23
165 N8a1a91d9fc0b41b5921c3c5d7d2f8cd7 schema:name doi
166 schema:value 10.1007/s00262-018-2178-0
167 rdf:type schema:PropertyValue
168 N92ebd64897fb4d3591984d3ec0fa3ee5 rdf:first sg:person.0645204640.48
169 rdf:rest Nf909d1171eb847fca15da6a3a60e6aa7
170 N959e2770ebed47e4923800f9a36b1baa rdf:first sg:person.011002122115.40
171 rdf:rest N3f7263a9ee234d29b370922233208814
172 Na41c3f55bae04ddab4b1aeb7ae63ce4e rdf:first sg:person.01141165754.09
173 rdf:rest N368035b43be346e896289202a58332fe
174 Na611e7b16be247e5b36a313e4f56c928 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Humans
176 rdf:type schema:DefinedTerm
177 Nb4689036456d47e38736d8f76ae0a8ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Male
179 rdf:type schema:DefinedTerm
180 Nb7a59aaa004d42efaad0de4afea580b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Programmed Cell Death 1 Receptor
182 rdf:type schema:DefinedTerm
183 Nbc895cb79c7b45d099d616cee8c7f2ec rdf:first sg:person.0661613401.39
184 rdf:rest N25687e812b814b52bf72a7ee35838654
185 Nc0cf6d16b5744b20b6e5588cf72f68ec schema:name dimensions_id
186 schema:value pub.1104264568
187 rdf:type schema:PropertyValue
188 Nc5b0c6138d314ddfbdf1940294700c67 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Follow-Up Studies
190 rdf:type schema:DefinedTerm
191 Nca7ac64e52eb433e813e050dfcc1eddb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name CTLA-4 Antigen
193 rdf:type schema:DefinedTerm
194 Ncf42516f8c224711ba84f33f89555f27 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Antibodies, Monoclonal
196 rdf:type schema:DefinedTerm
197 Nd0c6c659bb2e41bca0cd718121d7deab rdf:first sg:person.0606303163.09
198 rdf:rest Nde46a16c9d5b497fb41bf83ef2f9470a
199 Nd235dc8eb442488087db3bbb6a5d232d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Prognosis
201 rdf:type schema:DefinedTerm
202 Nde46a16c9d5b497fb41bf83ef2f9470a rdf:first sg:person.01125647410.05
203 rdf:rest Na41c3f55bae04ddab4b1aeb7ae63ce4e
204 Ndf6b459c94114249a48d504d237a1cef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
205 schema:name Diabetes Mellitus, Type 1
206 rdf:type schema:DefinedTerm
207 Ne1bb190f4be74d6cb7188f219c22b8dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
208 schema:name Retrospective Studies
209 rdf:type schema:DefinedTerm
210 Neb81680cc3b64cb1a240a72f5c76eaca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Diabetes Mellitus, Type 2
212 rdf:type schema:DefinedTerm
213 Nef53b4f6de4841d88763e88a06b83585 schema:name pubmed_id
214 schema:value 29808365
215 rdf:type schema:PropertyValue
216 Nf597e8851f8b41e1bfa8cd15b99139ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
217 schema:name Incidence
218 rdf:type schema:DefinedTerm
219 Nf5b743bc1bba41148486e9fe54ba4f80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
220 schema:name Middle Aged
221 rdf:type schema:DefinedTerm
222 Nf8338beeeeef41989a31d96aef3fa454 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
223 schema:name Adult
224 rdf:type schema:DefinedTerm
225 Nf909d1171eb847fca15da6a3a60e6aa7 rdf:first sg:person.01112142070.26
226 rdf:rest N430c1d0cb2dc4e7fbcb806880ab2e37f
227 Nff249fe6b2604d9baa777605380a2c00 rdf:first sg:person.07443060126.24
228 rdf:rest Nbc895cb79c7b45d099d616cee8c7f2ec
229 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
230 schema:name Medical and Health Sciences
231 rdf:type schema:DefinedTerm
232 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
233 schema:name Clinical Sciences
234 rdf:type schema:DefinedTerm
235 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
236 schema:name Immunology
237 rdf:type schema:DefinedTerm
238 sg:journal.1096240 schema:issn 0340-7004
239 1432-0851
240 schema:name Cancer Immunology, Immunotherapy
241 schema:publisher Springer Nature
242 rdf:type schema:Periodical
243 sg:person.01036155166.50 schema:affiliation grid-institutes:None
244 schema:familyName Resche-Rigon
245 schema:givenName Matthieu
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036155166.50
247 rdf:type schema:Person
248 sg:person.01054652653.34 schema:affiliation grid-institutes:grid.413328.f
249 schema:familyName Lebbé
250 schema:givenName Céleste
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054652653.34
252 rdf:type schema:Person
253 sg:person.011002122115.40 schema:affiliation grid-institutes:grid.413328.f
254 schema:familyName Gauci
255 schema:givenName Marie-Léa
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011002122115.40
257 rdf:type schema:Person
258 sg:person.01112142070.26 schema:affiliation grid-institutes:None
259 schema:familyName Vidal-Trecan
260 schema:givenName Tiphaine
261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112142070.26
262 rdf:type schema:Person
263 sg:person.01125647410.05 schema:affiliation grid-institutes:grid.413328.f
264 schema:familyName Pages
265 schema:givenName Cécile
266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125647410.05
267 rdf:type schema:Person
268 sg:person.01141165754.09 schema:affiliation grid-institutes:grid.413328.f
269 schema:familyName Mourah
270 schema:givenName Samia
271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141165754.09
272 rdf:type schema:Person
273 sg:person.01264446127.83 schema:affiliation grid-institutes:None
274 schema:familyName Boudou
275 schema:givenName Philippe
276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01264446127.83
277 rdf:type schema:Person
278 sg:person.01266110107.91 schema:affiliation grid-institutes:grid.413328.f
279 schema:familyName Basset-Seguin
280 schema:givenName Nicole
281 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266110107.91
282 rdf:type schema:Person
283 sg:person.014551573472.10 schema:affiliation grid-institutes:None
284 schema:familyName Gautier
285 schema:givenName Jean-François
286 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014551573472.10
287 rdf:type schema:Person
288 sg:person.015421213413.19 schema:affiliation grid-institutes:grid.413328.f
289 schema:familyName Da Meda
290 schema:givenName Laetitia
291 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015421213413.19
292 rdf:type schema:Person
293 sg:person.0602343615.33 schema:affiliation grid-institutes:grid.508487.6
294 schema:familyName Eftekhari
295 schema:givenName Pirayeh
296 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602343615.33
297 rdf:type schema:Person
298 sg:person.0606303163.09 schema:affiliation grid-institutes:grid.413328.f
299 schema:familyName Bagot
300 schema:givenName Martine
301 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606303163.09
302 rdf:type schema:Person
303 sg:person.0645204640.48 schema:affiliation grid-institutes:grid.413328.f
304 schema:familyName Baroudjian
305 schema:givenName Barouyr
306 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645204640.48
307 rdf:type schema:Person
308 sg:person.0661613401.39 schema:affiliation grid-institutes:grid.411149.8
309 schema:familyName Sassier
310 schema:givenName Marion
311 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661613401.39
312 rdf:type schema:Person
313 sg:person.07443060126.24 schema:affiliation grid-institutes:grid.508487.6
314 schema:familyName Pinel
315 schema:givenName Sylvine
316 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07443060126.24
317 rdf:type schema:Person
318 sg:person.0755365673.35 schema:affiliation grid-institutes:grid.5399.6
319 schema:familyName Rouby
320 schema:givenName Franck
321 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755365673.35
322 rdf:type schema:Person
323 sg:person.0757312465.10 schema:affiliation grid-institutes:grid.413328.f
324 schema:familyName Madelaine-Chambrin
325 schema:givenName Isabelle
326 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757312465.10
327 rdf:type schema:Person
328 sg:pub.10.1007/s00262-015-1689-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016520120
329 https://doi.org/10.1007/s00262-015-1689-1
330 rdf:type schema:CreativeWork
331 sg:pub.10.1007/s00262-016-1835-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007445664
332 https://doi.org/10.1007/s00262-016-1835-4
333 rdf:type schema:CreativeWork
334 sg:pub.10.1007/s00262-017-2033-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1086099345
335 https://doi.org/10.1007/s00262-017-2033-8
336 rdf:type schema:CreativeWork
337 sg:pub.10.1007/s00393-014-1415-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1046203416
338 https://doi.org/10.1007/s00393-014-1415-y
339 rdf:type schema:CreativeWork
340 sg:pub.10.1007/s00592-014-0647-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034654942
341 https://doi.org/10.1007/s00592-014-0647-2
342 rdf:type schema:CreativeWork
343 sg:pub.10.1007/s12185-016-2101-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007028663
344 https://doi.org/10.1007/s12185-016-2101-4
345 rdf:type schema:CreativeWork
346 sg:pub.10.1038/ni.1835 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021874855
347 https://doi.org/10.1038/ni.1835
348 rdf:type schema:CreativeWork
349 sg:pub.10.1038/nm.1964 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018401818
350 https://doi.org/10.1038/nm.1964
351 rdf:type schema:CreativeWork
352 sg:pub.10.1038/nri2925 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041192648
353 https://doi.org/10.1038/nri2925
354 rdf:type schema:CreativeWork
355 sg:pub.10.1038/sj.ijo.0803744 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033023159
356 https://doi.org/10.1038/sj.ijo.0803744
357 rdf:type schema:CreativeWork
358 grid-institutes:None schema:alternateName AP-HP Diabetology Department, Lariboisière Hospital, INSERM U1138; Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France
359 AP-HP Hormonology Department, Saint-Louis Hospital, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France
360 AP-HP Statistics Department, Saint-Louis Hospital, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France
361 schema:name AP-HP Diabetology Department, Lariboisière Hospital, INSERM U1138; Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France
362 AP-HP Hormonology Department, Saint-Louis Hospital, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France
363 AP-HP Statistics Department, Saint-Louis Hospital, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France
364 rdf:type schema:Organization
365 grid-institutes:grid.411149.8 schema:alternateName Regional Pharmacovigilance Center of Caen, Caen University Hospital, Caen, France
366 schema:name Regional Pharmacovigilance Center of Caen, Caen University Hospital, Caen, France
367 rdf:type schema:Organization
368 grid-institutes:grid.413328.f schema:alternateName AP-HP Dermatology Department, Saint-Louis Hospital, INSERM U976, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, 1, Avenue Claude Vellefaux, 75010, Paris, France
369 AP-HP Pharmacogenomic Laboratory, Saint-Louis Hospital, INSERM U976, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France
370 AP-HP Pharmacology Department, Saint-Louis Hospital, INSERM U976, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France
371 schema:name AP-HP Dermatology Department, Saint-Louis Hospital, INSERM U976, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, 1, Avenue Claude Vellefaux, 75010, Paris, France
372 AP-HP Pharmacogenomic Laboratory, Saint-Louis Hospital, INSERM U976, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France
373 AP-HP Pharmacology Department, Saint-Louis Hospital, INSERM U976, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France
374 rdf:type schema:Organization
375 grid-institutes:grid.508487.6 schema:alternateName AP-HP Regional Pharmacologilance Center, Fernand Widal Hospital, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France
376 schema:name AP-HP Regional Pharmacologilance Center, Fernand Widal Hospital, Université Paris Diderot-Paris VII, Sorbonne Paris Cité, Paris, France
377 rdf:type schema:Organization
378 grid-institutes:grid.5399.6 schema:alternateName Department of Clinical Pharmacology, Regional Pharmacovigilance Center of Marseille, Aix-Marseille University, Marseille, France
379 schema:name Department of Clinical Pharmacology, Regional Pharmacovigilance Center of Marseille, Aix-Marseille University, Marseille, France
380 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...